Patent details

93383 Product Name: "Combinaison de rilpivirine ou une forme thérapeutique équivalente qui en dérive telle que protégée par le brevet de base, tel qu'un sel pharmaceutiquement acceptable de rilpivirine, incluant le sel chlorhydrate de rilpivirine,emtricitabine, et ténofovir alafénamide, ou un sel pharmaceutiquement acceptable de celui-ci, en particulier le fumarate de ténofovir alafénamide"

Basic Information

Publication number:
93383
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP047870969
Legal Status:
Active
Application number:
93383
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/16/1112 Odefsey - emtricitabine
Marketing Authorization Type:
Marketing Authorization Date:
23/06/2016
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
20/12/2016
First Marketing Authorization date:
23/06/2016
Grant date:
17/03/2017
Activation date:
03/09/2024
Publication date:
17/03/2017
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
03/09/2029
SPC Extension Expiration:
03/09/2029
Rejection date:
Withdrawal date:

Owner

From:
20/12/2016
 
 

Name:
Janssen Sciences Ireland UC
Address:
Eastgate Village, Eastgate, Little Island, County Cork, Ireland (IE)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
20/12/2016
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
STOFFELS Paul
Address:
Belgium (BE)

Publication

Bulletin

1

Bulletin Heading:
SPC2
Bulletin edition number:
2017/02
Publication date:
22/06/2017
Description:
Section D : Granted supplementary protection certificates – I2 publication

2

Bulletin Heading:
SPC3
Bulletin edition number:
2025/04
Publication date:
04/03/2025
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:
30/09/2025
Annual Fee Number:
22
Annual Fee Amount:
420 Euro
Expected Payer:
Last Annual Fee Payment Date:
29/08/2024
Last Annual Fee Paid Number:
21
Last Annual Fee Paid Amount:
410 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
17/03/2017 Certificate 1
17/03/2017 Publication 1